M

Madrigal Pharmaceuticals
D

MDGL

576.68
USD
-9.97
(-1.70%)
مغلق
حجم التداول
9,573
الربح لكل سهم
-9
العائد الربحي
-
P/E
-45
حجم السوق
13,097,221,686
أصول ذات صلة الأخبار المقالات
المزيد

العنوان: Madrigal Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.